Article
Overview of molecular biomarkers for enhancing the management of cytologically indeterminate thyroid nodules and thyroid cancer.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists - 1 Jan 2000
Duick Daniel S
Abstract excerpt
OBJECTIVE: To provide information on molecular biomarkers that can help assess cytologically indeterminate thyroid nodules. METHODS: Published studies on immunohistologic, somatic mutation, gene expression classifier, microRNA, and thyrotropin receptor messenger RNA biomarkers are reviewed, and commercially available molecular test panels are described. RESULTS: Thyroid nodules are common, and clinical guidelines...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
